Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
SB202190 (FHPI) CAS：152121-30-7
SB202190 (FHPI)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1340 | 500mg | 415.00 | + Add to cart |
|
| R-C-1340 | 1g | 790.00 | + Add to cart |
|
| R-C-1340 | 2g | 1390.00 | + Add to cart |
|
|
|
||||
Product description
SB202190(FHPI)is a potent p38 MAPK inhibitor targeting p38α/β with IC50 of 50 nM/100 nM in cell-free assays,sometimes used instead of SB 203580 to investigate potential roles for SAPK2a/p38 in vivo.SB202190 inhibits endothelial cell apoptosis via induction of autophagy and heme oxygenase-1.SB202190 significantly suppresses Erastin‐dependent ferroptosis.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---SB202190 (FHPI) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
